Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Aristoff

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Tuberculosis (Edinburgh, Scotland)|March 19, 2010
Rifamycins--obstacles and opportunitiesPaul A Aristoff, George A Garcia, Paul D Kirchhoff, et al.
Plos One|June 4, 2011
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosisKaren G Anthony, Ulrich Strych, Kacheong R Yeung, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
Synthesis and biological evaluation of benzazepine oxazolidinone antibacterialsPaul D Johnson, Paul A Aristoff, Gary E Zurenko, et al.
The Journal of Biological Chemistry|July 12, 2012
A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF)Fengwei Bai, Oluwatoyin A Asojo, Pier Cirillo, et al.
Biochemical Pharmacology|December 8, 2011
Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureusMihai Ciustea, Sara Mootien, Adriana E Rosato, et al.
Biochemical Pharmacology|May 18, 2013
Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinonesYashang Lee, Sara Mootien, Carolyn Shoen, et al.
Journal of Medicinal Chemistry|November 9, 2007
Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compoundToni-Jo Poel, Richard C Thomas, Wade J Adams, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Tuberculosis (Edinburgh, Scotland)|March 19, 2010
Rifamycins--obstacles and opportunitiesPaul A Aristoff, George A Garcia, Paul D Kirchhoff, et al.
Plos One|June 4, 2011
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosisKaren G Anthony, Ulrich Strych, Kacheong R Yeung, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
Synthesis and biological evaluation of benzazepine oxazolidinone antibacterialsPaul D Johnson, Paul A Aristoff, Gary E Zurenko, et al.
The Journal of Biological Chemistry|July 12, 2012
A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF)Fengwei Bai, Oluwatoyin A Asojo, Pier Cirillo, et al.
Biochemical Pharmacology|December 8, 2011
Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureusMihai Ciustea, Sara Mootien, Adriana E Rosato, et al.
Biochemical Pharmacology|May 18, 2013
Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinonesYashang Lee, Sara Mootien, Carolyn Shoen, et al.
Journal of Medicinal Chemistry|November 9, 2007
Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compoundToni-Jo Poel, Richard C Thomas, Wade J Adams, et al.
Pageof 1